Website stats and analysis

Protein therapeutics have delivered tremendous value to patients, but have many limitations that cannot be corrected utilizing the natural amino acids. With Synthorx’s Expanded Genetic Alphabet platform technology, we can design and scale-up novel proteins with improved pharmacological properties, with the goal of making more efficacious, safer, and convenient therapeutics for patients. 

2.48 Rating by Usitestat

synthorx.com was registered 1 decade 2 months ago. It is a domain having .com extension. It is estimated worth of $ 8.95 and have a daily income of around $ 0.15. As no active threats were reported recently, synthorx.com is SAFE to browse.

Traffic Report

Daily Unique Visitors: Not Applicable
Daily Pageviews: Not Applicable

Estimated Valuation

Income Per Day: $ 0.15
Estimated Worth: $ 8.95

Search Engine Indexes

Google Indexed Pages: Not Applicable
Yahoo Indexed Pages: Not Applicable
Bing Indexed Pages: Not Applicable

Search Engine Backlinks

Google Backlinks: Not Applicable
Bing Backlinks: Not Applicable
Alexa BackLinks: Not Applicable

Safety Information

Google Safe Browsing: No Risk Issues
Siteadvisor Rating: Not Applicable
WOT Trustworthiness: Very Poor
WOT Privacy: Very Poor
WOT Child Safety: Very Poor

Website Ranks & Scores

Alexa Rank: Not Applicable
PageSpeed Score: Not Applicable
Domain Authority: 49 ON 100
Bounce Rate: Not Applicable
Time On Site: Not Applicable

Web Server Information

Hosted IP Address:

35.190.184.136

Hosted Country:

United States US

Location Latitude:

32.8886

Location Longitude:

-80.0075

Traffic Classification

Total Traffic: No Data
Direct Traffic: No Data
Referral Traffic: No Data
Search Traffic: No Data
Social Traffic: No Data
Mail Traffic: No Data
Display Traffic: No Data

Search Engine Results For synthorx.com

Home - Synthorx

- https://synthorx.com/

The Synthorx team. At Synthorx, we focus on making significant advancements in protein design to deliver optimized therapeutics – called Synthorins – to improve the lives of...


Synthorx - Home | Facebook

- https://www.facebook.com/synthorx

Synthorx. 450 likes. We're using our first-of-its-kind Expanded Genetic Alphabet platform technology to discover and develop optimized biologics for cancer and autoimmune...


Synthorx - THOR - Stock Price & News | The Motley Fool

- https://www.fool.com/quote/nasdaq/synthorx-inc/thor/

Real time Synthorx (THOR) stock price quote, stock graph, news & analysis.


Synthorx Inc Stock Price (THOR) - Investing.com

- https://www.investing.com/equities/synthorx

Synthorx, Inc. is a biopharmaceutical company. The Company is focused on prolonging and improving the lives of people suffering from cancer and autoimmune disorders.


Sanofi : Sanofi to acquire Synthorx to bolster its immuno ...

- https://www.sanofi.com/en/media-room/press-releases/2019/2019-12-09-07-00-00

Dec 09, 2019 · Sanofi to acquire Synthorx to bolster its immuno-oncology pipeline for $2.5 Billion. Proprietary immuno-oncology (IO) platform synergistic with Sanofi’s existing...


Sanofi : Sanofi to acquire Synthorx to bolster its immuno ...

- https://www.globenewswire.com/news-release/2019/12/09/1957603/0/en/Sanofi-Sanofi-to-acquire-Synthorx-to-bolster-its-immuno-oncology-pipeline-for-2-5-Billion.html

Dec 09, 2019 · Sanofi to acquire Synthorx to bolster its immuno-oncology pipeline for $2.5 Billion. Proprietary immuno-oncology (IO) platform synergistic with …


Synthorx Inc | LinkedIn

- https://www.linkedin.com/company/synthorx-inc-/

Synthorx, Inc. is a biotechnology company focused on prolonging and improving the lives of people with cancer and autoimmune disorders. Synthorx’s proprietary, first-of-its-kind...


Synthorx - Posts | Facebook

- https://www.facebook.com/synthorx/posts

Synthorx. 455 likes. We're using our first-of-its-kind Expanded Genetic Alphabet platform technology to discover and develop optimized biologics for cancer and autoimmune...


SYNTHORX, INC. : Stock Price | MarketScreener

- https://www.marketscreener.com/quote/stock/SYNTHORX-INC-47487022/

01/23: SYNTHORX, INC.: Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing,...


Sanofi Is Paying a 172% Premium to Buy Synthorx -- and It ...

- https://www.fool.com/investing/2019/12/10/sanofi-is-paying-a-172-premium-to-buy-synthorx-and.aspx

Dec 10, 2019 · The Synthorx deal isn't anywhere near the size of the Genzyme one, but it doesn't have to be. It is the right element at the right time to boost businesses that...


Sanofi to acquire immuno-oncology company Synthorx for $2 ...

- https://medcitynews.com/2019/12/sanofi-to-acquire-immuno-oncology-company-synthorx-for-2-5b/

Dec 10, 2019 · Synthorx’s lead drug candidate is THOR-707, an IL-2 therapeutic that it has in development both as a single agent and in combination with …


Mega deal: La Jolla startup Synthorx sells for $2.5 ...

- https://www.sandiegouniontribune.com/business/story/2019-12-09/mega-deal-la-jolla-startup-synthorx-sells-for-2-5-billion-to-sanofi

Dec 09, 2019 · The drug at the center of this new deal is Synthorx’s investigational medicine code-named THOR-707. Meant to treat solid tumors, the drug is …


Sanofi beat out 3 suitors and one last-minute bid in its ...

- https://www.fiercepharma.com/pharma/sanofi-beat-out-three-suitors-its-pricey-2-5b-buyout-biotech-synthorx

Dec 30, 2019 · Synthorx picked Sanofi out of a field of four suitors for IL-2 candidate THOR-707, ultimately nailing down a 172% premium on the biotech's Dec. 5 …


BIO101 EXAM 3 CH 25 Flashcards | Quizlet

- https://quizlet.com/450370456/bio101-exam-3-ch-25-flash-cards/

Which of the following are the two new nucleotides that have been created by the company Synthorx? a. Z b. H c. X d. Y. c. X d. Y. Why did early molecular geneticists know that...


Sanofi inks $2.5B Synthorx takeover to gain IL-2 cancer ...

- https://www.fiercebiotech.com/biotech/sanofi-inks-2-5b-synthorx-takeover-to-gain-il-2-cancer-drug

Dec 09, 2019 · Sanofi has struck a deal to buy Synthorx for $2.5 billion (€2.3 billion). The takeover, the first of Paul Hudson’s time as CEO, will give Sanofi control of an...

Page Resources Breakdown

Homepage Links Analysis

Home - Synthorx

Website Inpage Analysis

H1 Headings: 2 H2 Headings: 28
H3 Headings: Not Applicable H4 Headings: Not Applicable
H5 Headings: Not Applicable H6 Headings: Not Applicable
Total IFRAMEs: Not Applicable Total Images: 10
Google Adsense: Not Applicable Google Analytics: UA-118225458-1

Two Phrase Analysis

Words Occurrences Density Possible Spam
in vitro 4 0.685 % No
the first 4 0.685 % No
publishes first 3 0.514 % No
we are 3 0.514 % No
vitro translation 3 0.514 % No
2018 Synthorx 3 0.514 % No
Romesberg lab 3 0.514 % No
genetic information 3 0.514 % No
to improve 3 0.514 % No
CA 92037 2 0.342 % No
PCR amplified 2 0.342 % No
La Jolla 2 0.342 % No
publish the 2 0.342 % No
Torrey Pines 2 0.342 % No
first UBP 2 0.342 % No
2019 Synthorx 2 0.342 % No
of people 2 0.342 % No
Privacy Policy 2 0.342 % No
publishes on 2 0.342 % No
on the 2 0.342 % No

Four Phrase Analysis

Words Occurrences Density Possible Spam
medicine is in oursynthetic 2 0.342 % No
is in oursynthetic DNA 2 0.342 % No
La Jolla CA 92037 2 0.342 % No
Better medicine is in 2 0.342 % No
Application for THOR707 paving 1 0.171 % No
for THOR707 paving the 1 0.171 % No
THOR707 paving the way 1 0.171 % No
IND Application for THOR707 1 0.171 % No
the IND Application for 1 0.171 % No
from FDA for the 1 0.171 % No
FDA for the IND 1 0.171 % No
for the IND Application 1 0.171 % No
paving the way for 1 0.171 % No
the US Protein therapeutics 1 0.171 % No
for enrollment to proceed 1 0.171 % No
enrollment to proceed in 1 0.171 % No
to proceed in the 1 0.171 % No
way for enrollment to 1 0.171 % No
the way for enrollment 1 0.171 % No
in the US Protein 1 0.171 % No

Mobile Friendly Check


Mobile Friendly : Yes
Score : 99

Mobile viewport not set: 0
Text too small to read: 0
Uses incompatible plugins: 0
Content wider than screen: 0
Links too close together: 0.017846519928614
CMS: WORDPRESS
Locale: en_US
Roboted Resources: 2
Transient Fetch Failure Resources: 0

Websites Hosted on Same IP (i.e. 35.190.184.136)

Infutor Data Solutions - All Your Identity Resolution Needs

- infutor.com

Infutor's consumer data, intelligence, and identity resolution solutions help improve acquisition, increase omnichannel reach, and drive conversions.

  133,871   $ 93,600.00

Tobacco Free Florida | Smoking Cessation Information & Programs

- tobaccofreeflorida.com

Working to protect the people of Florida from the dangers of tobacco and smoking. Discover how to quit with the help of Tobacco Free Florida.

  2,202,532   $ 480.00

Cyara Home | Cyara

- cyara.com

Cyara is the world’s leading Automated Customer Experience Assurance Platform provider, helping leading brands deliver better CX with less effort, cost, time, and risk. Cyara...

  Not Applicable   $ 8.95

SlutBox | Amber Rose's Monthly Beauty & Fashion Box

- myslutbox.com

SlutBox is a monthly subscription by Amber Rose focused on beauty, fashion, body positivity and activism. Join MySlutBox.com to get yours!

  1,662,903   $ 720.00

Kuebix Transportation Management System | Industry's Ultimate TMS‎

- kuebix.com

Cloud-based transportation management system (TMS) provides freight intelligence & meets the requirements of every supply chain. Try Kuebix Software Now!

  589,629   $ 2,160.00

HTTP Header Analysis

Http-Version: 1.1
Status-Code: 200
Status: 200 OK
Server: nginx
Date: Sun, 10 Nov 2019 04:01:54 GMT
Content-Type: text/html; charset=UTF-8
Transfer-Encoding: chunked
Connection: keep-alive
Keep-Alive: timeout=20
Vary: Accept-Encoding,Cookie
X-Pingback: https://synthorx.com/xmlrpc.php
Link: ; rel=shortlink
X-Cacheable: SHORT
Cache-Control: max-age=600, must-revalidate
X-Cache: HIT: 3
X-Pass-Why:
X-Cache-Group: normal
Content-Encoding: gzip

Domain Information

Domain Registrar: Register.com, Inc.
Registration Date: 2014-02-26 1 decade 2 months 2 days ago
Last Modified: 2019-01-31 5 years 2 months 4 weeks ago

Domain Nameserver Information

Host IP Address Country
dns010.d.register.com 216.21.236.10 United States United States
dns014.b.register.com 216.21.232.14 United States United States
dns022.a.register.com 216.21.231.22 United States United States
dns142.c.register.com 216.21.235.142 United States United States

DNS Record Analysis

Host Type TTL Extra
synthorx.com A 14359 IP: 35.190.184.136
synthorx.com NS 14400 Target: dns014.b.register.com
synthorx.com NS 14400 Target: dns010.d.register.com
synthorx.com NS 14400 Target: dns142.c.register.com
synthorx.com NS 14400 Target: dns022.a.register.com
synthorx.com SOA 14400 MNAME: dns022.a.register.com
RNAME: root.register.com
Serial: 2014022517
Refresh: 28800
Retry: 7200
Expire: 604800
synthorx.com MX 14400 Target: synthorx-com.mail.protection.outlook.com
synthorx.com TXT 14400 TXT: v=spf1
include:spf.protection.outlook.com -all

Alexa Traffic Rank

Alexa Search Engine Traffic

Full WHOIS Lookup

Domain Name: SYNTHORX.COM
Registry Domain ID:
1848193028_DOMAIN_COM-VRSN
Registrar WHOIS Server:
whois.register.com
Registrar URL:
http://www.register.com
Updated Date:
2019-01-31T15:24:42Z
Creation Date:
2014-02-25T21:29:54Z
Registry Expiry Date:
2022-02-25T21:29:54Z
Registrar: Register.com, Inc.
Registrar
IANA ID: 9
Registrar Abuse Contact Email:
[email protected]
Registrar Abuse Contact Phone:
+1.8003337680
Domain Status: clientTransferProhibited
https://icann.org/epp#clientTransferProhibited
Name Server:
DNS010.D.REGISTER.COM
Name Server: DNS014.B.REGISTER.COM
Name
Server: DNS022.A.REGISTER.COM
Name Server:
DNS142.C.REGISTER.COM
DNSSEC: unsigned
URL of the ICANN Whois
Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last
update of whois database: 2019-11-10T04:02:15Z

Similarly Ranked Websites

Google Chrome - Download the Fast, Secure Browser from Google

- chrome.google.com

Get more done with the new Google Chrome. A more simple, secure, and faster web browser than ever, with Google’s smarts built-in. Download now.

1   $ 16,097,351,400.00

腾讯网

- qq.com

腾讯网从2003年创立至今,已经成为集新闻信息,区域垂直生活服务、社会化媒体资讯和产品为一体的互联网媒体平台。腾讯网下设新闻、科技、财经、娱乐、体育、汽车、时尚等多个频道,充分满足用户对不同类型资讯的需求。同时专注不同领域内容,打造精品栏目,并顺应技术发展趋势,推出网络直播等创新形式,改变了用户获取资讯的方式和习惯。

5   $ 3,219,470,280.00

Amazon.com. Spend less. Smile more.

- amazon.com

Free shipping on millions of items. Get the best of Shopping and Entertainment with Prime. Enjoy low prices and great deals on the largest selection of everyday essentials and...

8   $ 2,012,168,520.00

Instagram

- instagram.com

Create an account or log in to Instagram - A simple, fun & creative way to capture, edit & share photos, videos & messages with friends & family.

9   $ 1,788,594,480.00

Wikipedia

- wikipedia.org

Wikipedia is a free online encyclopedia, created and edited by volunteers around the world and hosted by the Wikimedia Foundation.

11   $ 1,463,395,680.00